Glucose, urea, and creatinine laboratory tests in people starting antiretroviral therapy with dolutegravir or efavirenz: a cohort study in Belo Horizonte, Brazil. RSD [Internet]. 2022 Apr. 12 [cited 2025 Dec. 21];11(5):e43711528541. Available from: https://rsdjournal.org/rsd/article/view/28541